PASTIC Dspace Repository

Effect of azithromycin and pefloxacin in treatment of acute enteritis based on clinical efficacy comparison

Show simple item record

dc.contributor.author Yang, Deying
dc.contributor.author Zhao, Deqin
dc.contributor.author Gong, Xufei
dc.contributor.author Chen, Xinrui
dc.date.accessioned 2022-11-17T07:52:00Z
dc.date.available 2022-11-17T07:52:00Z
dc.date.issued 2017-09-20
dc.identifier.citation Yang, D., Zhao, D., Gong, X., & Chen, X. (2017). Effect of azithromycin and pefloxacin in treatment of acute enteritis based on clinical efficacy comparison. Pakistan Journal of Pharmaceutical Sciences, 30. en_US
dc.identifier.issn 1011-601X
dc.identifier.uri http://142.54.178.187:9060/xmlui/handle/123456789/14045
dc.description.abstract This paper aims to compare and analyze clinical efficacy of azithromycin and pefloxacin in treatment of acute enteritis. The 160 patients with acute enteritis were randomly divided into a study group (n=80) treated with azithromycin, and a reference group (n=80) treated with pefloxacin. We compared overall treatment efficiency (markedly, effective, invalid), clinical symptoms and signs remission time (antipyretic time, antidiarrheal time, symptoms and signs disappearance time), interleukin-6 and C-reactive protein concentration before and after treatment, adverse reactions rate (nausea, abdominal pain, headache, etc.). In comparison of overall treatment efficiency of the two groups, the results showed that the study group was significantly superior to the reference group (P<0.05). In comparison of clinical symptoms and signs remission time of the two groups, the study group were significantly shorter than the reference group (P<0.05). At the same time, in comparison of levels of interleukin-6 and C-reactive protein concentration after treatment, the study group was significantly superior to the reference group (P<0.05). There was no significant difference between the two groups in incidence of adverse reactions (P<0.05). The efficacy of azithromycin for acute enteritis is better than that of pefloxacin, and it can significantly reduce clinical symptom remission time. Moreover, safe and reliable, it has great value in clinical application. en_US
dc.language.iso en en_US
dc.publisher Karachi:Pakistan Journal of Pharmaceutical Sciences, university of Karachi. en_US
dc.subject Azithromycin en_US
dc.subject pefloxacin en_US
dc.subject acute enteritis en_US
dc.subject therapeutic effect en_US
dc.subject comparative analysis en_US
dc.title Effect of azithromycin and pefloxacin in treatment of acute enteritis based on clinical efficacy comparison en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account